Bhupesh Dihenia M.D. P.A.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis2 trials

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Hoffmann-La Roche2 trials

Running trials

• Active, not recruiting

  A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

  NCT05269004· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)

  NCT04544436· Phase 3· Hoffmann-La Roche· Source